We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 08 DECEMBER 2016
PTAB Holds Oral Hearings In Tecfidera Patent IPR and Interference
Foley & Lardner LLP
On November 30, 2016, the USPTO Patent Trial and Appeal Board (PTAB) held oral hearings in two different inter partes proceedings involving the Biogen Tecfidera® patent with the latest expiation date.
United StatesIntellectual Property






